Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
PMID:34368359 Kannt A, et al
Advances in transcranial direct current stimulation for cognitive enhancement in healthy individuals
Disclaimer This article is only a very brief summary
Primarily used to treat Type 2 diabetes and assist with obesity management through weight loss, this drug class is dominated by industry leaders such as Novo Nordisk and Eli Lilly and Company
US$ 28.39
US$ 28.49
US$ 20.55
US$ 25.13
US$ 28.49
US$ 24.37
US$ 23.94
US$ 24.68
US$ 26.09
